top of page

HIV New Product Introduction Toolkit

A framework to support new product introduction in national health systems

White Icon Strip.png

Sign Up for our Newsletter

Home
Toolkit
Featured Products
COVID-19 Resources
Resource Library
External Toolkits
- WHO Diagnostics Toolkit
- Global AHD Toolkit
About CHAI
Contact
More

Use tab to navigate through the menu items.

Resource Library

All Posts
Product Adoption & Decision Making
Procurement Planning
Facility-Level Implementation
Stakeholder Engagement
Forecasting and Quantification
Monitoring and Uptake
Featured Product Resources
Registration
National-Level Planning & Budgeting
COVID-19

HIV Drug Resistance Testing Costing Tool

HIV Drug Resistance Testing Costing Tool

HIV Drug Resistance Testing Costing Tool

This tool was developed to support national HIV programs and ministries of health to estimate and compare the cost of the following two...

May 6, 2024

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

The GAP-f pDTG task team has developed a brief outlining product introduction and rollout considerations for national programmes when...

May 24, 2023

Pediatric DTG Introduction: Transition Plan Templates

Pediatric DTG Introduction: Transition Plan Templates

Pediatric DTG Introduction: Transition Plan Templates

Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French

Aug 16, 2021

Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children

Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children

Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...

Jul 20, 2021

CHAI Cost of Optimizing Second-Line Treatment (COST) Tool

CHAI Cost of Optimizing Second-Line Treatment (COST) Tool

CHAI Cost of Optimizing Second-Line Treatment (COST) Tool

The CHAI COST Tool is a model that helps to estimate the financial impact of switching existing second-line (2L) patients to optimized,...

Feb 4, 2020

CHAI ARV Phase-In / Phase-Out Tool

CHAI ARV Phase-In / Phase-Out Tool

CHAI ARV Phase-In / Phase-Out Tool

As national programs introduce new, generic ARVs they must plan how and when the new product will be phased-in to ensure smooth and...

Dec 1, 2017

CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions

CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions

CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions

This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through...

Nov 8, 2017

Best Practices for New Product Introduction

Best Practices for New Product Introduction

Best Practices for New Product Introduction

This presentation from the 2016 International AIDS Society Conference outlines key approaches to product introduction, including working...

Jul 23, 2016

Clinton Health Access Initiative

383 Dorchester Avenue, Suite 400

Boston, MA 02127

The goal of the HIV New Product Introduction Toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at HIVToolkit@clintonhealthaccess.org.

© 2022 Clinton Health Access Initiative - Global HIV Access Program

bottom of page